Maine proposal would legalize psilocybin mushroom therapy for adults, no medical diagnosis needed
Activists in Colorado have tabled revised versions of a pair of 2022 ballot initiatives to legalize psilocybin and create licensed “healing centers” where people can use the psychedelic for therapeutic purposes. The move comes as state lawmakers introduced a separate bill requiring a study into the effectiveness of herbal psychedelics.
The ballot measures — filed by Kevin Matthews, the campaign manager behind Denver’s historic 2019 vote to locally decriminalize psilocybin and entrepreneur Veronica Perez — are similar to earlier versions the attorneys filed with the Secretary’s office. state last month, with some key changes regarding the rollout of reform, promoting fairness and possession limits.
For the original initiatives, the campaign considered two options: one would have legalized a wide range of entheogenic substances, including DMT, ibogaine and mescaline, as well as establishing a regulatory model for psychedelic therapy. The other would originally have enacted the reform for psilocybin and psilocin alone.
But recognizing that regulators would face the daunting task of putting rules in place for multiple psychedelics, campaigners decided to take a different approach with the new measures. For both, there would be a two-tier regulatory model, where only psilocybin would be legalized and regulated for therapeutic use until June 2026, after which regulators could expand the policy change to include other psychedelics listed in proposal.
“We really wanted to make sure that the administration had the time to put in place an appropriate regulatory structure, first for psilocybin and then for any other natural medicine,” said Rick Ridder of RBI Strategies, spokesperson for the campaign, at Marijuana Moment Monday.
The decision to add additional psychedelics to the program would be made by the Department of Regulatory Agencies in consultation with a Natural Medicine Advisory Board that would be established. The council would consist of 15 members, including people with experience of psychedelic medicine in a scientific and religious context.
Another major change from previous versions is that the revised initiatives do not contain explicit “permissible” possession limits — a provision that was pushed back by some Colorado activists when the original measures were filed.
And unlike the last two versions of the initiatives, these new measures also include specific provisions intended to “ensure that the regulatory access program is fair and inclusive and to promote the licensing and provision of natural medicine services” for people who have been disproportionately affected. by the criminalization of drugs, who have difficulty accessing health care, have “a traditional or indigenous history with natural medicines” and military veterans.
These rules could involve, but are not limited to, reduced licensing fees, reduced costs for low-income people, and an annual review of “the effectiveness of these policies and programs.”
“I think this is a giant leap forward for mental health treatment in the state of Colorado,” Ridder said. “Looking at research results across the world, we see some very promising data about particularly healthy people with PTSD, with suicidal tendencies and at the end of life. And it’s just an opportunity to bring that kind of natural medicine and medical help to the citizens here in Colorado.
The two new initiatives are almost identical to each other, except that one contains a feature specifically allowing people to ask the courts to seal records of previous convictions that would be made legal under the proposal.
According to the proposals, the Department of Regulatory Agencies would be responsible for developing rules for a psychedelic therapy program where adults aged 21 and over could visit a licensed ‘healing centre’ to receive treatment under the guidance of a facilitator. qualified.
This latest filing comes more than two years after Denver became the first city in the United States to decriminalize psilocybin mushrooms. Various activists, including those involved in the 2019 campaign, have expressed interest in building on the reform.
Initiatives must always be assigned an official voting title and state summary before they are approved to begin collecting signatures. The measurements are program to receive a review and feedback hearing on February 3. If approved by state officials, activists will choose one of the measures to pursue and then must collect 124,632 valid signatures from registered voters to gain access to the ballot.
Colorado’s ballot initiatives seek to accomplish something similar to what California activists are actively pursuing. California advocates are collecting signatures for a ballot initiative to legalize psilocybin mushrooms in the state.
Meanwhile, in Colorado, Sen. Joann Ginal (D) and Rep. Alex Valdez (D) last week introduced a modest bill to create a plant-based medicine policy review committee in Colorado. a year who would be responsible for studying “the use of plants”. medication to support mental health,” according to a abstract. The election campaign is not affiliated with this legislative effort.
Marijuana Moment is already tracking more than 1,000 cannabis, psychedelics and drug bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, access our interactive maps, charts, and audience calendar so they don’t miss a thing.
Learn more about our Marijuana Bill Tracker and become a support on Patreon to gain access.
“The Policy Review Committee will report its findings and policy recommendations to the House of Representatives Public and Behavioral Health and Human Services Committee and the Senate Health and Human Services Committee, or to any successor commission; the governor; and the Department of Social Services,” he says.
Meanwhile, legislative efforts to enact psychedelic reform are also underway in other states across the country.
For example, a bill to decriminalize a wide range of psychedelic substances in Virginia was considered by a House of Delegates panel on Monday, only to be pushed back until 2023. But there is still a separate reform proposal but similar that is pending in the Senate.
Two Oklahoma Republican lawmakers recently introduced bills intended to promote research into the therapeutic potential of psilocybin, and one of the measures would further decriminalize low-level possession of the psychedelic.
A Utah GOP lawmaker also introduced a bill last week that would establish a task force to study and make recommendations on the therapeutic potential of psychedelic drugs and possible regulations for their legal use.
In Kansas, a lawmaker also recently introduced a bill to legalize the possession and low-level cultivation of psilocybin mushrooms.
A Republican lawmaker in Missouri introduced a bill this month to give residents with serious illnesses legal access to a range of psychedelic drugs like psilocybin, ibogaine and LSD through an expanded version of the law. existing state on the right to try.
California Senator Scott Wiener (D) told Marijuana Moment in a recent interview that his bill to legalize possession of psychedelics has a 50/50 chance of reaching the governor’s office this year. He has already authorized the entire Senate and two Assembly committees during the first half of the two-year session.
In Michigan, two state senators introduced a bill in September to legalize the possession, cultivation, and delivery of various plant and mushroom-derived psychedelics like psilocybin and mescaline.
Washington state lawmakers also introduced legislation this month that would legalize what the bill calls “supported psilocybin experiments” by adults 21 and older.
In Vermont, a broad coalition of lawmakers representing nearly a third of the House introduced a bill to decriminalize drug possession.
New Hampshire lawmakers have tabled measures to decriminalize psilocybin and all drugs.
Last year, Connecticut’s governor signed a law that includes language requiring the state to conduct a study into the therapeutic potential of psilocybin mushrooms.
At the congressional level, bipartisan lawmakers sent a letter to the Drug Enforcement Administration (DEA) this month urging the agency to allow terminally ill patients to use psilocybin as an experimental treatment without fear of federal prosecution.
Virginia House committee pushes back bill to decriminalize psychedelics until 2023, but Senate proposal still pending
Photo courtesy of Dick Culbert.